Mr. Mariusz Olejniczak reports

ACRX INVESTMENT IN WPD'S FORMER SUBSIDIARY

WPD Pharmaceuticals S.A. (WPD Poland), the successor to WPD Pharmaceuticals Inc.'s former subsidiary, has received additional cash funds of 1,009,992.90 zloty (approximately $358,275 (Canadian)) from ACRX Investments Ltd. (ACRX) in exchange for the issuance of 93,345 shares of WPD Poland pursuant to an investment agreement between ACRX and WPD Poland. These funds were registered by the Polish court on Jan. 23, 2025. Following the investment by ACRX, the company's percentage share ownership in WPD Poland was reduced to approximately 4.0 per cent of the total issued shares of WPD Poland. The company no longer controls WPD Poland and is a minority shareholder. The largest shareholders of WPD Poland are ACRX and Houston Pharmaceuticals Inc.

The company has no active business. The company will seek to raise additional funds to provide general working capital. Subject to raising additional capital, the company intends to identify and evaluate opportunities for investment in or acquisition of companies dedicated to fostering growth and innovation in the sectors of biopharmaceuticals, health care or technology. There can be no assurance that the company will secure additional financing, or complete an acquisition of other businesses, assets or investments.

We seek Safe Harbor.